Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Northwest Biotherapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
NWBO
Over the counter
8731
https://nwbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Northwest Biotherapeutics Inc
Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors
- Mar 21st, 2024 3:09 pm
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification
- Feb 6th, 2024 2:30 pm
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma
- Dec 21st, 2023 2:30 pm
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
- Nov 22nd, 2023 2:30 pm
Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application
- Oct 13th, 2023 1:30 pm
Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board
- Sep 12th, 2023 2:00 pm
Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application
- Aug 29th, 2023 2:02 pm
Scroll